Cite
Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank.
MLA
Wu, Zeni, et al. “Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 32, no. 11, Nov. 2023, pp. 1564–71. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-23-0772.
APA
Wu, Z., Trabert, B., Guillemette, C., Caron, P., Bradwin, G., Graubard, B. I., Weiderpass, E., Ursin, G., Langseth, H., & McGlynn, K. A. (2023). Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 32(11), 1564–1571. https://doi.org/10.1158/1055-9965.EPI-23-0772
Chicago
Wu, Zeni, Britton Trabert, Chantal Guillemette, Patrick Caron, Gary Bradwin, Barry I Graubard, Elisabete Weiderpass, Giske Ursin, Hilde Langseth, and Katherine A McGlynn. 2023. “Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank.” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 32 (11): 1564–71. doi:10.1158/1055-9965.EPI-23-0772.